Question: Neuropsychological test batteries and cognitive endpoints in AD clinical trials
CDR-SB as primary endpoint: sensitivity in early AD
Needs new evidence2 verified (technical)
1/5 publication-ready
Findings metrics
—
total
—
verified
—
pending
—
rejected